Ferguson Wellman Capital Management Inc. cut its holdings in Marsh & McLennan Companies, Inc. (NYSE:MMC – Free Report) by 5.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,828 shares of the financial services provider’s stock after selling 333 shares during the quarter. Ferguson Wellman Capital Management Inc.’s holdings in Marsh & McLennan Companies were worth $1,422,000 at the end of the most recent quarter.
A number of other hedge funds have also modified their holdings of MMC. Norges Bank acquired a new stake in Marsh & McLennan Companies during the 4th quarter valued at $1,236,186,000. Stifel Financial Corp boosted its stake in shares of Marsh & McLennan Companies by 551.0% during the fourth quarter. Stifel Financial Corp now owns 2,224,932 shares of the financial services provider’s stock valued at $472,599,000 after acquiring an additional 1,883,146 shares during the last quarter. Amundi increased its position in Marsh & McLennan Companies by 81.1% during the 4th quarter. Amundi now owns 4,072,976 shares of the financial services provider’s stock worth $860,824,000 after purchasing an additional 1,823,807 shares in the last quarter. GAMMA Investing LLC raised its stake in Marsh & McLennan Companies by 32,120.9% in the 1st quarter. GAMMA Investing LLC now owns 1,515,670 shares of the financial services provider’s stock valued at $369,869,000 after purchasing an additional 1,510,966 shares during the last quarter. Finally, Raymond James Financial Inc. purchased a new position in Marsh & McLennan Companies in the 4th quarter valued at about $207,278,000. 87.99% of the stock is owned by hedge funds and other institutional investors.
Marsh & McLennan Companies Trading Up 0.9%
Shares of MMC stock opened at $219.27 on Friday. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.44. Marsh & McLennan Companies, Inc. has a fifty-two week low of $207.21 and a fifty-two week high of $248.00. The firm’s 50 day moving average price is $226.47 and its two-hundred day moving average price is $225.50. The stock has a market cap of $108.04 billion, a price-to-earnings ratio of 26.77, a price-to-earnings-growth ratio of 2.70 and a beta of 0.83.
Insider Transactions at Marsh & McLennan Companies
In other Marsh & McLennan Companies news, CEO Dean Michael Klisura sold 9,569 shares of the company’s stock in a transaction dated Monday, March 31st. The shares were sold at an average price of $245.00, for a total value of $2,344,405.00. Following the completion of the transaction, the chief executive officer now directly owns 20,935 shares of the company’s stock, valued at $5,129,075. This represents a 31.37% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Paul Beswick sold 2,237 shares of Marsh & McLennan Companies stock in a transaction that occurred on Thursday, April 3rd. The stock was sold at an average price of $246.00, for a total value of $550,302.00. Following the sale, the senior vice president now owns 13,522 shares in the company, valued at $3,326,412. This represents a 14.20% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.
Analysts Set New Price Targets
A number of equities analysts have recently weighed in on the stock. Jefferies Financial Group boosted their price objective on shares of Marsh & McLennan Companies from $237.00 to $244.00 and gave the company a “hold” rating in a research report on Friday, April 11th. Redburn Atlantic started coverage on Marsh & McLennan Companies in a report on Tuesday, March 25th. They issued a “buy” rating and a $281.00 price target for the company. Barclays raised their price objective on Marsh & McLennan Companies from $246.00 to $249.00 and gave the stock an “equal weight” rating in a report on Friday, April 11th. Wells Fargo & Company upped their target price on Marsh & McLennan Companies from $223.00 to $232.00 and gave the company an “equal weight” rating in a research note on Thursday, April 10th. Finally, UBS Group raised their price target on Marsh & McLennan Companies from $259.00 to $261.00 and gave the stock a “buy” rating in a research note on Wednesday, April 9th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $241.93.
Get Our Latest Research Report on Marsh & McLennan Companies
Marsh & McLennan Companies Company Profile
Marsh & McLennan Cos., Inc is a professional services firm, which engages in offering clients advice and solutions in risk, strategy, and people. It operates through the Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment is involved in risk management activities, as well as insurance and reinsurance broking and services.
Featured Articles
- Five stocks we like better than Marsh & McLennan Companies
- Best Stocks Under $5.00
- Ignore the Noise—Samsara Stock Is Still a Strong Buy
- What Are Treasury Bonds?
- 3 Stocks Set to Double—And There’s Still Time to Buy
- What is the MACD Indicator and How to Use it in Your Trading
- Analysts Can’t Get Enough of These Little-Known Biopharma Stocks
Want to see what other hedge funds are holding MMC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MMC – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.